EUVIMEDEUVIMED entdecken
Crossref

Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program

Alicja Nowowiejska-Wiewióra, Krystian Wita, Zofia Mędrala, Lidia Tomkiewicz-Pająk, Kamil Bujak, Katarzyna Mizia-Stec, Piotr Brzychczy, Mariusz Gąsior, Zbigniew Gąsior, Aleksandra Kulbat, Zbigniew Kalarus, Wojciech Wojakowski und 4 weitere

Kardiologia Polska · 2023

DOI: 10.33963/kp.a2023.0045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kardiologia Polska, 2023. Verfasst von Alicja Nowowiejska-Wiewióra und 15 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland. anwiewiora@sccs.pl. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Myocardial Infarction, Dyslipidemias. Die Arbeit wurde bisher 19-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients after acute myocardial infarction (AMI) are at very high cardiovascular (CV) risk. Therefore, appropriate management of dyslipidemia with adequate lipid-lowering therapy is crucial for preventing subsequent CV events in these patients. AIMS: Our analysis aimed to assess the treatment of dyslipidemia and attainment of low-density lipoprotein cholesterol (LDL-C) treatment goals in patients after AMI who participated in the Managed Care for Acute Myocardial Infarction Survivors (MACAMIS) program. METHODS: This study is a retrospective analysis of consecutive patients with AMI who agreed to participate and completed the 12-month MACAMIS program at one of three tertiary referral cardiovascular centers in Poland between October 2017 and January 2021. RESULTS: 1499 patients after AMI were enrolled in the study. High-intensity statin therapy was prescribed for 85.5% of analyzed patients on hospital discharge. Combined therapy with high-intensity statin and ezetimibe increased from 2.1% on hospital discharge to 18.2% after 12 months. In the whole study cohort, 20.4% of patients achieved the LDL-C target of < 55 mg/dl ( < 1.4 mmol/l), and 26.9% of patients achieved at least a 50% reduction in LDL-C level one year after AMI. CONCLUSIONS: Our analysis suggests that participation in the managed care program might be associated with improved quality of dyslipidemia management in AMI patients. Nonetheless, only one-fifth of patients who completed the program achieved the treatment goal for LDL-C. This highlights the constant need for optimizing lipid-lowering therapy to meet treatment targets and reduce CV risk in patients after AMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsMyocardial InfarctionDyslipidemiasHumansCholesterol, LDLGoalsRetrospective StudiesTreatment OutcomeManaged Care Programs

Stichwörter der Autor:innen

cardiovascular risklipid-lowering therapylow-density lipoprotein cholesterolmyocardial infarctionsecondary prevention

Substanzen

Cholesterol, LDLHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland. anwiewiora@sccs.pl.
  • 1st Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
  • 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Jagiellonian University Medical College, Institute of Cardiology, Department of Interventional Cardiology, Kraków, Poland.
  • Clinical Department of Interventional Cardiology, John Paul II Hospital, Kraków, Poland.
  • Student Scientific Group of Modern Cardiac Therapy at the Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.

Zitieren

APA

Nowowiejska-Wiewióra, A., Wita, K., Mędrala, Z., Tomkiewicz-Pająk, L., Bujak, K., Mizia-Stec, K., Brzychczy, P., Gąsior, M., Gąsior, Z., Kulbat, A., Kalarus, Z., Wojakowski, W., Trzeciak, P., Witkowski, A., Banach, M., & Legutko, J. (2023). Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program. Kardiologia Polska. https://doi.org/10.33963/kp.a2023.0045

Vancouver

Nowowiejska-Wiewióra A, Wita K, Mędrala Z, Tomkiewicz-Pająk L, Bujak K, Mizia-Stec K, et al. Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program. Kardiologia Polska. 2023. doi:10.33963/kp.a2023.0045

BibTeX
@article{NowowiejskaWiewira2023,
  author = {Nowowiejska-Wiewióra, Alicja and Wita, Krystian and Mędrala, Zofia and Tomkiewicz-Pająk, Lidia and Bujak, Kamil and Mizia-Stec, Katarzyna and Brzychczy, Piotr and Gąsior, Mariusz and Gąsior, Zbigniew and Kulbat, Aleksandra and Kalarus, Zbigniew and Wojakowski, Wojciech and Trzeciak, Przemysław and Witkowski, Adam and Banach, Maciej and Legutko, Jacek},
  title = {Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program},
  journal = {Kardiologia Polska},
  year = {2023},
  doi = {10.33963/kp.a2023.0045}
}
Kostenlos starten →